Search research articles
Contact Us
Filters
Showing results (661-670 of 734) with videos related to
Page
of 74
Sort By:
Leukemia & Lymphoma
|
July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies
Graham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.
British Journal of Haematology
|
July 23, 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
Olalekan O Oluwole, Krimo Bouabdallah, Javier Muñoz, et al.
The Lancet. Haematology
|
June 18, 2024
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Kim M Linton, Umberto Vitolo, Wojciech Jurczak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure
César O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Leukemia
|
July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J Iqbal, T C Greiner, K Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Blood
|
March 15, 2017
<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in mice
Idoia García-Ramírez, Saber Tadros, Inés González-Herrero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR
Hillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma
Ronald Levy, Kristen N Ganjoo, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Page
of 74
Search research articles
Search
Showing results (661-670 of 734) with videos related to
Sort By:
Page
of 74
Leukemia & Lymphoma
|
July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies
Graham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.
British Journal of Haematology
|
July 23, 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma
Olalekan O Oluwole, Krimo Bouabdallah, Javier Muñoz, et al.
The Lancet. Haematology
|
June 18, 2024
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Kim M Linton, Umberto Vitolo, Wojciech Jurczak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure
César O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Leukemia
|
July 13, 2007
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J Iqbal, T C Greiner, K Patel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Loretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Blood
|
March 15, 2017
<i>Crebbp</i> loss cooperates with <i>Bcl2</i> overexpression to promote lymphoma in mice
Idoia García-Ramírez, Saber Tadros, Inés González-Herrero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR
Hillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma
Ronald Levy, Kristen N Ganjoo, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Page
of 74